OTCMKTS:IVVI

Ivivi Technologies Competitors

$0.0000
0.00 (0.00 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Ivivi Technologies (OTCMKTS:IVVI) Vs. MDT, SONVY, VAR, MASI, GNGBY, and LIVN

Should you be buying IVVI stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Ivivi Technologies, including Medtronic (MDT), Sonova (SONVY), Varian Medical Systems (VAR), Masimo (MASI), Getinge (GNGBY), and LivaNova (LIVN).

Ivivi Technologies (OTCMKTS:IVVI) and Medtronic (NYSE:MDT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Medtronic, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
Medtronic031812.91

Medtronic has a consensus target price of $124.2692, suggesting a potential upside of 0.30%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Ivivi Technologies.

Profitability

This table compares Ivivi Technologies and Medtronic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
Medtronic12.69%9.71%5.30%

Earnings & Valuation

This table compares Ivivi Technologies and Medtronic's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
Medtronic$28.91 billion5.78$4.79 billion$4.5926.99

Medtronic has higher revenue and earnings than Ivivi Technologies.

Institutional and Insider Ownership

79.2% of Medtronic shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Comparatively, 0.5% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Medtronic beats Ivivi Technologies on 8 of the 9 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Sonova, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
Sonova06302.33

Profitability

This table compares Ivivi Technologies and Sonova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
SonovaN/AN/AN/A

Earnings & Valuation

This table compares Ivivi Technologies and Sonova's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
Sonova$2.96 billion6.18$489.96 million$1.4938.08

Sonova has higher revenue and earnings than Ivivi Technologies.

Institutional and Insider Ownership

1.1% of Sonova shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Sonova beats Ivivi Technologies on 3 of the 4 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Institutional and Insider Ownership

87.0% of Varian Medical Systems shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Comparatively, 0.8% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
Varian Medical Systems8.50%18.45%8.08%

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Varian Medical Systems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
Varian Medical Systems35001.63

Varian Medical Systems has a consensus target price of $159.3571, suggesting a potential downside of 10.00%. Given Varian Medical Systems' higher possible upside, analysts plainly believe Varian Medical Systems is more favorable than Ivivi Technologies.

Earnings & Valuation

This table compares Ivivi Technologies and Varian Medical Systems' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
Varian Medical Systems$3.17 billion5.13$269.20 million$3.9145.29

Varian Medical Systems has higher revenue and earnings than Ivivi Technologies.

Summary

Varian Medical Systems beats Ivivi Technologies on 6 of the 7 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

81.6% of Masimo shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Comparatively, 11.5% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Masimo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
Masimo20.30%15.75%13.12%

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and Masimo, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
Masimo02502.71

Masimo has a consensus target price of $272.20, suggesting a potential upside of 13.63%. Given Masimo's higher possible upside, analysts clearly believe Masimo is more favorable than Ivivi Technologies.

Earnings and Valuation

This table compares Ivivi Technologies and Masimo's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
Masimo$937.84 million14.12$196.22 million$3.2274.39

Masimo has higher revenue and earnings than Ivivi Technologies.

Summary

Masimo beats Ivivi Technologies on 7 of the 8 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Getinge (OTCMKTS:GNGBY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

0.0% of Getinge shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Getinge's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
Getinge10.51%17.30%7.90%

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and Getinge, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
Getinge11502.57

Earnings and Valuation

This table compares Ivivi Technologies and Getinge's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
Getinge$2.81 billion2.76$129.29 millionN/AN/A

Getinge has higher revenue and earnings than Ivivi Technologies.

Summary

Getinge beats Ivivi Technologies on 6 of the 7 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

89.1% of LivaNova shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Comparatively, 0.5% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and LivaNova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ivivi TechnologiesN/AN/AN/A
LivaNova-21.88%5.55%3.07%

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and LivaNova, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ivivi Technologies0000N/A
LivaNova04202.33

LivaNova has a consensus target price of $69.3333, suggesting a potential downside of 14.79%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than Ivivi Technologies.

Earnings and Valuation

This table compares Ivivi Technologies and LivaNova's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ivivi TechnologiesN/AN/AN/AN/AN/A
LivaNova$1.08 billion3.65$-155,180,000.00$3.0826.42

Ivivi Technologies has higher earnings, but lower revenue than LivaNova.

Summary

LivaNova beats Ivivi Technologies on 6 of the 8 factors compared between the two stocks.


Ivivi Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Medtronic logo
MDT
Medtronic
2.7$123.90flat$167.03 billion$28.91 billion47.29
Sonova logo
SONVY
Sonova
0.9$56.74flat$18.27 billion$2.96 billion38.08Increase in Short Interest
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$177.07flat$16.26 billion$3.17 billion60.43
Masimo logo
MASI
Masimo
1.6$239.55flat$13.24 billion$937.84 million62.22Insider Selling
Getinge logo
GNGBY
Getinge
0.6$30.56flat$7.77 billion$2.81 billion25.25Upcoming Earnings
Analyst Upgrade
Gap Down
LivaNova logo
LIVN
LivaNova
1.5$81.37flat$3.96 billion$1.08 billion-18.92Analyst Report
CNMD
CONMED
1.6$130.45flat$3.78 billion$955.10 million-3,261.25
InMode logo
INMD
InMode
1.5$83.53flat$2.67 billion$156.36 million60.09Analyst Downgrade
Outset Medical logo
OM
Outset Medical
1.0$54.50flat$2.33 billionN/A0.00Analyst Upgrade
BioLife Solutions logo
BLFS
BioLife Solutions
2.1$33.59flat$1.12 billion$27.37 million-46.01Insider Selling
Increase in Short Interest
NTUS
Natus Medical
1.1$28.63flat$969.81 million$495.52 million-52.05
TransMedics Group logo
TMDX
TransMedics Group
1.6$29.13flat$797.29 million$23.60 million-20.81Increase in Short Interest
Gap Down
AxoGen logo
AXGN
AxoGen
1.5$19.42flat$791.79 million$106.71 million-30.83News Coverage
SMLR
Semler Scientific
1.2$110.00flat$738.87 million$32.77 million77.46Insider Selling
Decrease in Short Interest
News Coverage
ViewRay logo
VRAY
ViewRay
1.3$4.43flat$712.35 million$87.78 million-4.98
Stereotaxis logo
STXS
Stereotaxis
0.6$8.35flat$615.89 million$28.90 million-75.91
Cutera logo
CUTR
Cutera
1.3$30.78flat$547.36 million$181.71 million-17.01
Zynex logo
ZYXI
Zynex
1.8$15.19flat$529.45 million$45.47 million46.03
Edap Tms logo
EDAP
Edap Tms
1.3$9.06flat$264.03 million$50.23 million-151.00Increase in Short Interest
Second Sight Medical Products logo
EYES
Second Sight Medical Products
0.8$8.24flat$191.58 million$3.38 million-4.31Decrease in Short Interest
BioSig Technologies logo
BSGM
BioSig Technologies
0.5$4.21flat$133.84 millionN/A0.00News Coverage
FONR
FONAR
1.1$17.98flat$117.84 million$85.69 million16.96
IRIDEX logo
IRIX
IRIDEX
0.9$7.41flat$115.01 million$43.45 million-13.47
Soleno Therapeutics logo
SLNO
Soleno Therapeutics
1.9$1.22flat$97.26 millionN/A-1.61Increase in Short Interest
ENDRA Life Sciences logo
NDRA
ENDRA Life Sciences
0.6$2.28flat$94.85 million$10,000.00-1.24Analyst Upgrade
Increase in Short Interest
electroCore logo
ECOR
electroCore
1.4$1.82flat$88.23 million$2.39 million-2.30Decrease in Short Interest
Electromed logo
ELMD
Electromed
1.8$10.09flat$87.13 million$32.47 million24.02Analyst Downgrade
Helius Medical Technologies logo
HSDT
Helius Medical Technologies
1.5$17.56flat$40.58 million$1.50 million-1.00Analyst Upgrade
Increase in Short Interest
Fc Global Realty logo
FCRE
Fc Global Realty
0.5$0.10flat$38.87 million$40,000.000.00Gap Up
CHF Solutions logo
CHFS
CHF Solutions
1.7$5.33flat$32.18 million$5.51 million-0.11High Trading Volume
Increase in Short Interest
Viveve Medical logo
VIVE
Viveve Medical
0.9$3.01flat$31.13 million$6.57 million-0.01
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$4.40flat$27.14 million$15.09 million0.00
PEYE
Precision Optics
0.4$1.62flat$21.49 million$9.92 million-16.20
Vaso logo
VASO
Vaso
0.9$0.09flat$17.02 million$75.75 million4.59Gap Up
STRR
Star Equity
0.1$3.21flat$15.80 million$114.18 million-1.02
GTHP
Guided Therapeutics
0.3$0.80flat$10.54 million$40,000.00-3.33Gap Up
Micron Solutions logo
MICR
Micron Solutions
0.3$3.01flat$10.12 million$17.50 million21.50Increase in Short Interest
NIMU
Non-Invasive Monitoring Systems
0.5$0.03flat$2.49 millionN/A0.00Upcoming Earnings
RSLSD
ReShape Lifesciences
0.4N/AN/A$1.94 million$610,000.000.00High Trading Volume
Nexeon MedSystems logo
NXNN
Nexeon MedSystems
0.7$0.55flat$1.12 millionN/A0.00
ARDMQ
Aradigm
0.0$0.05flat$764,000.00N/A0.00
MAGAA
Magna-Lab
0.7$0.58flat$678,000.00N/A3.19High Trading Volume
Gap Up
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.03flat$367,000.00N/A0.00Gap Up
IMRIS logo
IMRSQ
IMRIS
0.5$0.01flat$364,000.00N/A0.00
SCIE
SpectraScience
0.5$0.00flat$265,000.00N/A0.00Decrease in Short Interest
ULGX
Urologix
0.6$0.01flat$166,000.00N/A0.00Gap Up
AKSY
Aksys
0.0$0.00flat$0.00N/A0.00
Escalon Medical logo
ESMC
Escalon Medical
0.5$0.40flat$0.00$9.40 million-6.67Increase in Short Interest
Gap Down
HRTT
Heart Tronics
0.0$0.02flat$0.00N/A0.00High Trading Volume
Gap Up
NWCI
NewCardio
0.5$0.00flat$0.00N/A0.00
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.